Skip to main content
. 2018 Mar 8;136(4):389–398. doi: 10.1001/jamaophthalmol.2018.0185

Table 1. Clinical Characteristics in Pediatric Patients With Complete CSNB With TRPM1 Mutations.

Clinical Features Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 Patient 7
Presenting age 8 mo ± 4 mo 8 mo ± 4 mo 8 mo ± 4 mo 8 mo ± 4 mo 8 mo ± 4 mo 8 mo ± 4 mo 8 mo ± 4 mo
Strabismus Yes; X(T)a (stereo 6/9) Yes; E(T) and CN 4 palsy (stereo 0/9) Yes; X(T) (stereo 5/9) X (stereo 8/9)b Yes; X(T)a Yes; E(T) (stereo 3/9) Yes; X(T) (stereo 0/9)
Nystagmus Yesc No No No Yesc No Yes
Initial refractive error (SE) OD: −2.00;
OS: −3.50
OD: +1.00;
OS: 0.25
OD: −8.50;
OS: −8.50
OD: −8.25;
OS: −7.75
OD: −1.00;
OS: −1.50
OD: −3.50;
OS: −3.50
OD: +3.75;
OS: +3.75
Systemic studies Yes (MRI normal) No Yes (Stickler syndrome evaluation) Yes (Stickler syndrome evaluation) No Yes (MRI normal) Yes (MRI normal)
Initial clinical diagnosis Spasmus mutans CN 4 palsy Pathologic myopia Pathologic myopia Myopia Infantile nystagmus Opsoclonus
Age nyctalopia reported Progressive, preteen Progressive, child Progressive, child None reported None reported Toddler Child
First BCVA, y 5 5 5 5 6 4 4
First BCVA (Snellen/logMAR) OD:20/50 (0.400); OS:20/30 (0.176) OD: 20/50 (0.400); OS:20/70 (0.544) OD:20/40 (0.301); OS:20/40 (0.301) OD:20/20 (0.000); OS:20/25 (0.097) OD: 20/70 (0.544); OS: 20/70 (0.544) OD: 20/40 (0.301); OS: 20/30 (0.176) OD: 20/100 (0.699); OS: 20/200 (1.00)
Age final, y 15 14 11 9 9 15 10
BCVA final, Snellen (logMAR) OD: 20/20 (0.000); OS: 20/20 (0.000) OD: 20/40 (0.301); OS: 20/70d (0.544) OD: 20/25 (0.097); OS: 20/20 (0.000) OD: 20/20 (0.000); OS: 20/20 (0.097) OD: 20/80d (0.602); OS: 20/60 (0.477) OD: 20/20 (0.000); OS: 20/20 (0.000) OD: 20/40 (0.301); OS: 20/50 (0.398)
Final refractive error (SE) OD: −4.00;
OS: −4.25
OD: −5.50;
OS: −6.50
OD: −13.75;
OS: −14.00
OD: −9.00;
OS: −8.00
OD: −6.50;
OS: −6.00
OD: −13.50;
OS: −14.00
OD: −9.00;
OS: −10.25
Color discrimination Full Full Full Full Full Full Full
Fundus ON: tilted; myopic; few hypo-pigmented areas ON: tilted, temporal pallor; myopic fundus ON: tilted; myopic, lattice ON: tilted; myopic, cystic retinal tuft OD ON: tilted; tessellated, myopic fundus ON: tilted; myopic ON: tilted; tessellated, myopic fundus
GVF NML
OU
Mild I-2e depression (full to I-4e) OU; small central scotoma OU Mild I-2e depression (full to I-4e) OU Mild I-2e depression (full to I-4e) OU Mild I-2e depression (full to I-4e) OU Mild I-2e depression (full to I-4e) OU; small central scotoma OU Mild I-2e depression (full to I-4e) OU
FST, dBe OD: −34.5;
OS: −31.5
OD: −28.2;
OS: −26.6
OD: −31.4;
OS: −29.6
OD: −26.6;
OS: −28.9
OD: −22.5;
OS: −27.8
OD: −29.2;
OS: −27.4
OD: −36.0;
OS: −35.5
ffERG final Electronegative DA 3.0 ERG Electronegative DA 3.0 ERG Electronegative DA 3.0 ERG Electronegative DA 3.0 ERG Electronegative DA 3.0 ERG Electronegative DA 3.0 ERG Electronegative DA 3.0 ERG
SD-OCT macula, CST, um; CV, mm2 OD: 226 μm, 8.4 mm2; OS: 250 μm, 8.5 mm2 OD: 246 μm, 6.01 mm2; OS: 234 μm, ND OD: ND; OS: 387 μm, 11.68 mm2 OD: 237 μm, 7.85 mm2; OS: 236 μm, 7.82 mm2 OD: 259 μm, 8.29 mm2; OS: 275 μm, 8.01 mm2 ND OD: 233 μm, 8.56 mm2; OS: 235 μm, 7.91 mm2

Abbreviations: BCVA, best-corrected visual acuity; CN 4, congenital fourth nerve palsy; CSNB, congenital stationary night blindness; CST, central subfield thickness; CV, central volume; DA, dark-adapted; ERG, electroretinogram; ffERG, full field electroretinogram; ffFST, full-field sensitivity threshold test; FST, sensitivity threshold test; GVF, Goldmann visual field; E(T), intermittent esotropia; MRI, magnetic resonance imaging; ND, not done; NML, normal; SD-OCT, spectral-domain optical coherence tomography; SE, spherical equivalent; Stereo, stereopsis by Titmus testing given as number correct; Strab, strabismus; X(T), intermittent exotropia.

a

Had strabismus surgery.

b

Initially had orthophoria and then developed exophoria.

c

Nystagmus resolved by age 2 years in patients 1 and 5.

d

Amblyopia.

e

Normal FST is less than or equal to −55.00 dB.